Drug Pipeline

Mycophenolate Sodium Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Phase 3
2
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-06 NCT07412470
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults…		 Trial sites expanded: 16 -> 23 locations
2026-05-21 NCT07412470
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults…		 Trial sites expanded: 10 -> 16 locations
Active Studies by Phase
Phase 2/3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07412470 A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults… Kidney Transplant Rejection Recruiting
Phase 2
NCT04195633 Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for… Acute Leukemia Recruiting
Phase 1
NCT04375631 CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell… Recurrent Acute Myeloid Leukemia Recruiting
Sponsors Running Mycophenolate Sodium Trials
Fred Hutchinson Cancer Center (2) Sanofi (1)
Disease Areas
Leukemia (2) Acute Myeloid Leukemia (AML) (2) Myelodysplastic Syndromes (MDS) (2) Acute Lymphoblastic Leukemia (ALL) (1) Chronic Lymphocytic Leukemia (CLL) (1) Chronic Myeloid Leukemia (CML) (1) Hodgkin Lymphoma (1) Follicular Lymphoma (1) Mantle Cell Lymphoma (1)
Get alerts when Mycophenolate Sodium trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free